Comprehensive Update in Management of Diabetes Mellitus and Obesity Including Role of SGLT2 Inhibitors and Bariatric Surgery

Course overview

At the conclusion of this program, the participant will be able to: 1. Summarize recommendations from clinical practice guidelines regarding diabetes. 2. Discuss clinical evidence and place in therapy for oral diabetes and GLP-1 agonist agents. 3. Discuss the growing evidence and role of SGLT2 inhibitors and DPP-4 inhibitors within diabetes and non-diabetes patients. 4. Analyze role of bariatric surgery in management of morbid obesity and diabetes. 5. Describe complications and medication-related changed post-bariatric surgery. 6. Evaluate and develop medication regimens post-bariatric surgery through case studies.